| Physical interaction with human tumor-derived p53 mutants inhibits p63 activities S Strano, G Fontemaggi, A Costanzo, MG Rizzo, O Monti, A Baccarini, ... Journal of Biological Chemistry 277 (21), 18817-18826, 2002 | 290 | 2002 |
| Structure of the human gene for the proliferating cell nuclear antigen S Travali, DH Ku, MG Rizzo, L Ottavio, R Baserga, B Calabretta Journal of Biological Chemistry 264 (13), 7466-7472, 1989 | 206 | 1989 |
| The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal M Prisco, A Hongo, MG Rizzo, A Sacchi, R Baserga Molecular and cellular biology, 1997 | 194 | 1997 |
| Interference with p53 protein inhibits hematopoietic and muscle differentiation. S Soddu, G Blandino, R Scardigli, S Coen, A Marchetti, MG Rizzo, ... The Journal of cell biology 134 (1), 193-204, 1996 | 162 | 1996 |
| Importance of introns in the growth regulation of mRNA levels of the proliferating cell nuclear antigen gene L Ottavio, CD Chang, MG Rizzo, S Travali, C Casadevall, R Baserga Molecular and cellular biology 10 (1), 303-309, 1990 | 124 | 1990 |
| The microRNA miR‐92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms I Manni, S Artuso, S Careccia, M Giulia Rizzo, R Baserga, G Piaggio, ... The FASEB Journal 23 (11), 3957-3966, 2009 | 105 | 2009 |
| A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes S Careccia, S Mainardi, A Pelosi, A Gurtner, D Diverio, R Riccioni, ... Oncogene 28 (45), 4034-4040, 2009 | 99 | 2009 |
| A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas G Regazzo, I Terrenato, M Spagnuolo, M Carosi, G Cognetti, L Cicchillitti, ... Journal of Experimental & Clinical Cancer Research 35, 1-11, 2016 | 86 | 2016 |
| Wild-type p53 modulates apoptosis of normal, IL-3 deprived, hematopoietic cells. G Blandino, R Scardigli, MG Rizzo, M Crescenzi, S Soddu, A Sacchi Oncogene 10 (4), 731-737, 1995 | 77 | 1995 |
| miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia A Pelosi, S Careccia, V Lulli, P Romania, G Marziali, U Testa, S Lavorgna, ... Oncogene 32 (31), 3648-3654, 2013 | 73 | 2013 |
| A peroxidase peroxiredoxin 1-specific redox regulation of the novel FOXO3 microRNA target let-7 BL Hopkins, M Nadler, JJ Skoko, T Bertomeu, A Pelosi, PM Shafaei, ... Antioxidants & redox signaling 28 (1), 62-77, 2018 | 63 | 2018 |
| CPTH6, a thiazole derivative, induces histone hypoacetylation and apoptosis in human leukemia cells D Trisciuoglio, Y Ragazzoni, A Pelosi, M Desideri, S Carradori, ... Clinical cancer research 18 (2), 475-486, 2012 | 63 | 2012 |
| Wt-p53 action in human leukaemia cell lines corresponding to different stages of differentiation MG Rizzo, A Zepparoni, B Cristofanelli, R Scardigli, M Crescenzi, ... British journal of cancer 77 (9), 1429-1438, 1998 | 52 | 1998 |
| The promoter of the human proliferating cell nuclear antigen (PCNA) gene is bidirectional MG Rizzo, L Ottavio, S Travali, B Kaminska, R Baserga Experimental Cell Research 188 (2), 286-293, 1990 | 52 | 1990 |
| Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study F Marchesi, A Tendas, D Giannarelli, C Viggiani, S Gumenyuk, D Renzi, ... Bone marrow transplantation 52 (1), 154-156, 2017 | 46 | 2017 |
| Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras B Cristofanelli, B Valentinis, S Soddu, MG Rizzo, A Marchetti, G Bossi, ... Oncogene 19 (29), 3245-3255, 2000 | 44 | 2000 |
| Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes S Soddu, G Blandino, R Scardigli, R Martinelli, MG Rizzo, M Crescenzi, ... Molecular and cellular biology, 1996 | 39 | 1996 |
| Analysis of p73 expression pattern in acute myeloid leukemias: lack of ΔN-p73 expression is a frequent feature of acute promyelocytic leukemia MG Rizzo, E Giombini, D Diverio, M Vignetti, A Sacchi, U Testa, ... Leukemia 18 (11), 1804-1809, 2004 | 36 | 2004 |
| Abrogation of the requirements for added growth factors in 3T3 cells constitutively expressing the p53 and IGF-1 genes. XX Gai, MG Rizzo, J Lee, A Ullrich, R Baserga Oncogene Research 3 (4), 377-386, 1988 | 34 | 1988 |
| Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative … F Marchesi, G Regazzo, F Palombi, I Terrenato, A Sacconi, M Spagnuolo, ... Journal of Experimental & Clinical Cancer Research 37, 1-12, 2018 | 27 | 2018 |
Marco CrescenziSenior Scientist, Istituto Superiore di SanitàVerified email at iss.it
